Physician profile
Lauren Basque
NPI 1770318776
$583.84
in general payments reported to CMS, 2019-2025
16 companies · $532 in 2025
The $532 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $52.32 · 2025: $532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $583.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $138.89 | 2025 | |
| Exact Sciences Corporation | $58.38 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $53.98 | 2025 | Wegovy |
| Axsome Therapeutics, INC. | $50.91 | 2024-2025 | Auvelity |
| Madrigal Pharmaceuticals | $38.15 | 2025 | Rezdiffra |
| Astellas Pharma US INC | $26.41 | 2025 | Veozah |
| Pfizer INC. | $26.26 | 2025 | |
| Janssen Pharmaceuticals, INC | $25.81 | 2025 | Spravato |
| Glaxosmithkline, LLC. | $24.99 | 2025 | Arexvy, Shingrix |
| Phathom Pharmaceuticals, INC. | $24.11 | 2025 | Voquezna |
| Otsuka America Pharmaceutical, INC. | $22.41 | 2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $21.78 | 2025 | Caplyta |
| Lilly USA, LLC | $20.35 | 2025 | Zepbound |
| Inspire Medical Systems, INC. | $19.13 | 2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $17.24 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $15.04 | 2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Basque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.